Table 1.

Characteristics of type 1 VWD and control participants from which ECFCs were isolated

Type 1 VWD (N = 8)Controls (N = 4)
Median age (range) 33.5 (25-64) 23.5 (21-42) 
Sex (F/M) 6/2 2/2 
% O-type blood 83  75 
Median baseline VWF:Ag (IU/mL) (range) 0.43 (0.20-0.53) 0.73 (0.44-0.87) 
Median baseline VWF activity (IU/mL) (range) 0.35 (0.28-0.56) 0.73 (0.42-0.85) 
Median ISTH-BAT Bleeding Score (range) 9 (4-15) 2 (0-4) 
Type 1 VWD (N = 8)Controls (N = 4)
Median age (range) 33.5 (25-64) 23.5 (21-42) 
Sex (F/M) 6/2 2/2 
% O-type blood 83  75 
Median baseline VWF:Ag (IU/mL) (range) 0.43 (0.20-0.53) 0.73 (0.44-0.87) 
Median baseline VWF activity (IU/mL) (range) 0.35 (0.28-0.56) 0.73 (0.42-0.85) 
Median ISTH-BAT Bleeding Score (range) 9 (4-15) 2 (0-4) 

ABO genotype was only available for 6/8 patients with type 1 VWD.

P ≤ .01.

or Create an Account

Close Modal
Close Modal